Loading...
Loading...
Wright Medical Group, Inc.
WMGI today announced that it has received approval from the U.S. Food and Drug Administration to conduct an Investigational Device Exemption clinical study to investigate use of the INBONE Total Ankle Replacement with Calcaneal Stem for treatment of end stage ankle arthritis or revision of a failed ankle replacement with subtalar joint insufficiency.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in